What is NDC 70121-2250?

70121-2250 is the product NDC for Romidepsin, Romidepsin 5 mg/mL injection, solution, concentrate, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals LLC, NDC labeler code 70121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Romidepsin?

1 other product NDC are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Romidepsin NDC 70121-2250 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70121-2250Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70121-2250Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70121-2250-1	7012122500170121225001	1 VIAL in 1 CARTON (70121-2250-1) / 5.5 mL in 1 VIALMarketed from Jun 2, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Romidepsin
Generic name (nonproprietary): romidepsin
Active ingredients: Romidepsin — 5 mg/mL
Dosage form: Injection, Solution, Concentrate
Route: Intravenous
Labeler: Amneal Pharmaceuticals LLCNDC labeler code 70121
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 219099
Marketing start: Jun 2, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Bile Salt Export Pump Inhibitors (Mechanism)Histone Deacetylase Inhibitors (Mechanism)Organic Anion Transporter 1 Inhibitors (Mechanism)Organic Anion Transporting Polypeptide 1B1 Inhibitors (Mechanism)Organic Anion Transporting Polypeptide 1B3 Inhibitors (Mechanism)Organic Cation Transporter 2 Inhibitors (Mechanism)
Identifiers: Product ID 70121-2250_a007605f-1e3d-4174-b62c-999ebbe27ed5SPL ID a007605f-1e3d-4174-b62c-999ebbe27ed5SPL set ID 61894b77-f29c-4a81-ad85-bd3a698233a4RxCUI 2289413UNII CX3T89XQBKUPC 0370121225010
Pharmacologic class: Histone Deacetylase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470121225001 followed by a unit qualifier and the quantity

Package 70121-2250-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 4, 2025.

Indications (excerpt from the label)

Romidepsin injection is indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy. Romidepsin injection is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous T-cell lymphoma (CTCL) in adult patients who have received at least one prior systemic therapy. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70121-2250

What is NDC 70121-2250?: 70121-2250 is the product NDC for Romidepsin, Romidepsin 5 mg/mL injection, solution, concentrate, listed with the FDA by Amneal Pharmaceuticals LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Romidepsin.
What is the active ingredient?: Romidepsin.
Who is the labeler?: Amneal Pharmaceuticals LLC, NDC labeler code 70121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Romidepsin?: 1 other product NDC are listed under this name. See all Romidepsin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Romidepsin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Romidepsin	—	Kit	Fresenius Kabi USA, LLC	63323-926	63323-0926-88